Skip to content
OpenCapital
Get started

ALX Oncology Holdings Inc. ALXO Q4 2024 Annual earnings

Reported March 6, 2025 · Before market open

EPS-$0.55Beat by $0.17
EPS estimate-$0.72

Next report

Aug 11, 2026 (In 1 week)
EPS estimate-$0.15

Versus estimates

Diluted EPS

Q1 2026-$0.17Miss by $0.02Q4 2025-$0.42Miss by $0.04Q3 2025-$0.41Miss by $0.04Q2 2025-$0.49Miss by $0.03Q1 2025-$0.58Miss by $0.11
Q4 2024-$0.55Beat by $0.17

Ask the moment ALX Oncology Holdings Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did ALX Oncology Holdings Inc. report Q4 2024 earnings?
ALX Oncology Holdings Inc. (ALXO) reported Q4 2024 earnings on March 6, 2025 before market open.
What were ALX Oncology Holdings Inc.'s Q4 2024 revenue and EPS?
ALX Oncology Holdings Inc. reported eps of $-0.55 for Q4 2024.
Did ALX Oncology Holdings Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.72 by $0.17.
Where can I find ALX Oncology Holdings Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-034761) directly on SEC EDGAR. The filing index links above go to sec.gov.